Australia's future drug costs less than government figures, says report
This article was originally published in Scrip
Executive Summary
The cost of drugs under Australia's state-funded pharmaceutical benefits scheme (PBS) will not spiral out of control as predicted by government figures, says a new report by the consultancy Access Economics.